Isoniazid, pyrazinamide, rifampicin
Sold as Co-afaris paed, Co-ripyso paed, Co-orizit paed
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Macleods Pharmaceuticals SA (Pty) Ltd1 of 3 cancelled | Co-afaris paed, Co-ripyso paed, Co-orizit paed | 75/50/150 | 520306, 520307.306, 520308.306 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Co-afaris paed 75/50/150 tablets EACH TABLET CONTAINS:ISONIAZID 50,0 mg; PYRAZINAMIDE 150,0 mg; RIFAMPICIN 75,0 mg | 75/50/150Tablets | 52030652/20.2.3/0306 | Registered | Not determined | None |
| Co-ripyso paed 75/50/150 tablets EACH TABLET CONTAINS ISONIAZID 50,0 mg, PYRAZINAMIDE 150,0 mg, RIFAMPICIN 75,0 mg | 75/50/150Tablets | 520307.30652/20.2.3/0307.306 | Registered | Not determined | None |
| Co-orizit paed 75/50/150 tablets EACH TABLET CONTAINS ISONIAZID 50,0 mgPYRAZINAMIDE 150,0 mgRIFAMPICIN 75,0 mg | 75/50/150Tablets | 520308.30652/20.2.3/0308.306 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Isoniazid
Consolidated Schedules 06 July 2026, line 6819
S4: Pyrazinamide
Consolidated Schedules 06 July 2026, line 7685
S4: Rifampicin
Consolidated Schedules 06 July 2026, line 7802
S3: Pyrazinamide
- when intended for oral use.
Consolidated Schedules 06 July 2026, line 4189
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.